Elevated body mass and hyperglycaemia activate pro-inflammatory pathways via the receptor for advanced glycation end products (RAGE), potentially enhancing glioma growth by upregulating RAGE expression and suppressing antitumor immune responses [65]. The gene discussed is AGER; the disease is central nervous system cancer.